RESEARCH GROUPS

DARWIN EU® - Drug Utilisation Studies on GLP-1 Agonists

DARWIN EU® - Drug utilization study of prescription opioids

DARWIN EU® - DUS in patients with major depressive disorder

DARWIN EU® - DUS of Antibiotics in the 'Watch' category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use.

DARWIN EU® - DUS of medicines with prokinetic properties in children and adults diagnosed with gastroparesis

DARWIN EU® - Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer

DARWIN EU® - Frailty and polypharmacy among adults aged 18 and above with cancer at the time of diagnosis

DARWIN EU® - Incidence of Myoclonus in heart failure: a descriptive analysis in patients treated with sacubitril/valsartan and other treatments

DARWIN EU® - Incidence of suicidality in patients with specific chronic skin conditions

DARWIN EU® - Multiple myeloma: patient characterisation, treatments and survival in the period 2012-2022

DARWIN EU® - Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations

DARWIN EU® - Suicidality following exposure to doxycycline

DARWIN EU® - Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus

DARWIN EU® - Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications

DARWIN EU® - Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications (P3 C1-004)

DARWIN EU® - Uptake of meningococcal vaccines by the target population in Europe

DARWIN EU® - Use of take-home naloxone for opioid overdose treatment

DARWIN EU® -Characterisation of acute renal outcomes and severe diabetic complications during the use of metformin and iodinated contrast agents

DARWIN EU® ? Characterisation of aliskiren users (P4-C1-017)

DARWIN EU® ? Effectiveness of COVID-19 vaccines on severe COVID-19 and post-acute outcomes of SARS-CoV-2 infection